))
Is this miracle drug the answer for aging dogs?
Manage episode 398958557 series 2843557
Contenido proporcionado por Vet Candy. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Vet Candy o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Loyal, the biotech trailblazer in pet longevity, has embarked on a groundbreaking journey with the launch of its STAY study, administering the first dose of the promising LOY-002 drug to Boo, an 11-year-old Whippet. This monumental trial is not just a medical first but a beacon of hope for pet owners dreaming of more quality time with their aging furry friends.
LOY-002, the latest innovation from Loyal, is at the forefront of extending the healthy, vibrant years of senior dogs. With an ambitious vision, the study aims to redefine aging in canines, blending cutting-edge science with heartfelt care.
The trial is monumental, standing as the most extensive of its kind. Over 50 independent veterinary clinics are joining forces, welcoming over 1,000 senior dogs to partake in this four-year journey. The goal? To pave the way for LOY-002's FDA approval, promising a future where man's best friend stays by their side, healthier and happier, for longer.
▷ LET’S BECOME FRIENDS!!
🔥Subscribe to our YouTub channel : https://tinyurl.com/zctkzy8
🔥Join the Vet Candy Circle at https://www.myvetcandy.com/circle
🔥Follow us on Facebook at https://www.facebook.com/myvetcandy
🔥Follow us on Instagram at https://www.instagram.com/myvetcandy
🔥Get our merch!! 100% proceeds go to charity!
#veterinary #veterinarypodcast #veterinarybusiness #veterinary news
101 episodios
Compartir
